Globeflex Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.57M | Buy |
10,645
+51
| +0.5% | +$11.2K | 0.33% | 91 |
|
|
2026
Q1 | $2M | Buy |
10,594
+6,003
| +131% | +$1.05M | 0.3% | 92 |
|
|
2025
Q4 | $780K | Buy |
+4,591
| New | +$704K | 0.12% | 186 |
|
|
2025
Q2 | – | Sell |
-8,073
| Closed | -$1M | – | 440 |
|
|
2025
Q1 | $1M | Hold |
8,073
| – | – | 0.09% | 168 |
|
|
2024
Q4 | $994K | Buy |
8,073
+3,000
| +59% | +$354K | 0.08% | 186 |
|
|
2024
Q3 | $565K | Buy |
+5,073
| New | +$556K | 0.05% | 251 |
|
|
2023
Q4 | – | Sell |
-965
| Closed | -$125K | – | 491 |
|
|
2023
Q3 | $125K | Hold |
965
| – | – | 0.01% | 359 |
|
|
2023
Q2 | $120K | Hold |
965
| – | – | 0.01% | 362 |
|
|
2023
Q1 | $141K | Hold |
965
| – | – | 0.02% | 364 |
|
|
2022
Q4 | $154K | Sell |
965
-174
| -15% | -$25.5K | 0.02% | 355 |
|
|
2022
Q3 | $152K | Hold |
1,139
| – | – | 0.03% | 372 |
|
|
2022
Q2 | $178K | Hold |
1,139
| – | – | 0.04% | 332 |
|
|
2022
Q1 | $177K | Hold |
1,139
| – | – | 0.04% | 351 |
|
|
2021
Q4 | $145K | Sell |
1,139
-11
| -1% | -$1.45K | 0.03% | 381 |
|
|
2021
Q3 | $150K | Sell |
1,150
-6,265
| -84% | -$947K | 0.03% | 353 |
|
|
2021
Q2 | $1.32M | Hold |
7,415
| – | – | 0.24% | 146 |
|
|
2021
Q1 | $1.22M | Buy |
7,415
+102
| +1% | +$16.8K | 0.22% | 150 |
|
|
2020
Q4 | $1.21M | Buy |
7,313
+194
| +3% | +$28.9K | 0.26% | 128 |
|
|
2020
Q3 | $1.01M | Sell |
7,119
-1,440
| -17% | -$179K | 0.27% | 125 |
|
|
2020
Q2 | $944K | Sell |
8,559
-1,171
| -12% | -$129K | 0.24% | 136 |
|
|
2020
Q1 | $970K | Hold |
9,730
| – | – | 0.3% | 109 |
|
|
2019
Q4 | $1.45M | Buy |
9,730
+3,770
| +63% | +$513K | 0.27% | 109 |
|
|
2019
Q3 | $764K | Hold |
5,960
| – | – | 0.17% | 207 |
|
|
2019
Q2 | $850K | Buy |
5,960
+3
| +0.1% | +$403 | 0.18% | 195 |
|
|
2019
Q1 | $852K | Hold |
5,957
| – | – | 0.18% | 200 |
|
|
2018
Q4 | $738K | Buy |
5,957
+2,849
| +92% | +$423K | 0.18% | 197 |
|
|
2018
Q3 | $523K | Buy |
3,108
+2
| +0.1% | +$344 | 0.1% | 287 |
|
|
2018
Q2 | $535K | Buy |
+3,106
| New | +$508K | 0.11% | 284 |
|
|
2014
Q2 | – | Sell |
-3,400
| Closed | -$471K | – | 644 |
|
|
2014
Q1 | $471K | Sell |
3,400
-300
| -8% | -$45.2K | 0.05% | 290 |
|
|
2013
Q4 | $468K | Hold |
3,700
| – | – | 0.06% | 289 |
|
|
2013
Q3 | $340K | Sell |
3,700
-18,944
| -84% | -$1.53M | 0.04% | 311 |
|
|
2013
Q2 | $1.56M | Buy |
+22,644
| New | +$1.38M | 0.21% | 133 |
|
Other funds holding JAZZ
Globeflex Capital's JAZZ Position: Q2 2026 in Review
Globeflex Capital increased its Jazz Pharmaceuticals (JAZZ) stake by 0.48% in Q2 2026, buying an estimated $11.2K and bringing the position to 10,645 shares worth $2.57M. The position accounts for 0.33% of the portfolio, ranked #91.
Globeflex Capital first reported a position in JAZZ in Q2 2013 and has held it in 32 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Globeflex Capital held 10,645 shares of Jazz Pharmaceuticals worth $2.57M as of Q2 2026.
- Globeflex Capital bought 51 Jazz Pharmaceuticals shares in Q2 2026, an estimated $11.2K.
- Jazz Pharmaceuticals made up 0.33% of Globeflex Capital's portfolio in Q2 2026, its #91 holding.
- Globeflex Capital first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.